Catheter ablation of cardiac arrhythmias during pregnancy: Safety, outcomes, and physical activity considerations – a narrative review

Background

Cardiac arrhythmias increasingly complicate pregnancy, affecting 68–166/100,000 pregnancy-related hospitalizations in the US, driven by advanced maternal age, congenital heart disease, and comorbidities. First-line pharmacotherapy carries risks including teratogenicity, hemodynamic disturbance, fetal growth restriction, and preterm delivery.